CanadaBis Capital Inc (CANB) - Total Liabilities

Latest as of October 2025: CA$16.64 Million CAD ≈ $12.03 Million USD

Based on the latest financial reports, CanadaBis Capital Inc (CANB) has total liabilities worth CA$16.64 Million CAD (≈ $12.03 Million USD) as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CanadaBis Capital Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

CanadaBis Capital Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how CanadaBis Capital Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CANB total asset value.

CanadaBis Capital Inc Competitors by Total Liabilities

The table below lists competitors of CanadaBis Capital Inc ranked by their total liabilities.

Company Country Total Liabilities
INVO Fertility, Inc.
NASDAQ:IVF
USA $12.98 Million
Jet.AI Inc.
NASDAQ:JTAI
USA $3.71 Million
Phoenix Spree Deutschland Ltd
LSE:PSDL
UK GBX315.43 Million
Strategic Equity Capital Closed Fund
LSE:SEC
UK GBX329.00K
GEMINA LABS LTD
F:8I7
Germany €6.25 Million
Bohra Industries Limited
NSE:BOHRAIND
India Rs62.65 Million
Aclarion Inc
NASDAQ:ACON
USA $699.75K
Ngenic AB
ST:NGENIC
Sweden Skr65.29 Million

Liability Composition Analysis (2016–2025)

This chart breaks down CanadaBis Capital Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CanadaBis Capital Inc (CANB) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.33 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.68 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CanadaBis Capital Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CanadaBis Capital Inc (2016–2025)

The table below shows the annual total liabilities of CanadaBis Capital Inc from 2016 to 2025.

Year Total Liabilities Change
2025-07-31 CA$16.62 Million
≈ $12.02 Million
-3.01%
2024-07-31 CA$17.13 Million
≈ $12.39 Million
+9.70%
2023-07-31 CA$15.62 Million
≈ $11.30 Million
+21.60%
2022-07-31 CA$12.84 Million
≈ $9.29 Million
+12.05%
2021-07-31 CA$11.46 Million
≈ $8.29 Million
+26.13%
2020-07-31 CA$9.09 Million
≈ $6.57 Million
+262.60%
2019-07-31 CA$2.51 Million
≈ $1.81 Million
+7702.88%
2018-07-31 CA$32.12K
≈ $23.24K
+124.54%
2017-07-31 CA$14.30K
≈ $10.35K
--
2016-07-31 CA$0.00
≈ $0.00
--

About CanadaBis Capital Inc

V:CANB Canada Drug Manufacturers - Specialty & Generic
Market Cap
$1.53 Million
CA$2.12 Million CAD
Market Cap Rank
#30357 Global
#1525 in Canada
Share Price
CA$0.02
Change (1 day)
+0.00%
52-Week Range
CA$0.01 - CA$0.05
All Time High
CA$0.55
About

CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through two segments: Cultivation and Extraction. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the production and wholesale distribution of cannabis extract products th… Read more